HLA-DP: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:DP Pept TCR.JPG|DP Peptide TCR | |||
</gallery> | |||
Latest revision as of 05:41, 3 March 2025
HLA-DP is a type of human leukocyte antigen (HLA) that plays a crucial role in the immune system. It is part of the HLA class II group of antigens, which are primarily expressed in antigen-presenting cells.
Structure[edit]
HLA-DP is a heterodimer, consisting of an alpha (DPA) and beta (DPB) chain. Both chains are anchored in the membrane. The alpha chain is approximately 33-35 kDa and is composed of two Ig-like domains. The beta chain is approximately 28-30 kDa and is composed of two Ig-like domains.
Function[edit]
HLA-DP molecules are responsible for presenting peptides from extracellular proteins to the T cell receptor on CD4+ T cells. This is a crucial step in the immune response to pathogens.
Genetics[edit]
The genes encoding the HLA-DP alpha and beta chains are located on the short arm of chromosome 6 (6p21.3). There are many alleles for each gene, leading to a high level of polymorphism in the HLA-DP molecule.
Clinical significance[edit]
HLA-DP has been associated with a number of diseases, including rheumatoid arthritis, celiac disease, and certain types of cancer. It has also been implicated in the response to certain infections, such as Hepatitis B.
See also[edit]
|
|
|
-
DP Peptide TCR

